Safety and Tolerability of Z-100 in Patients With Early HIV Infection
This study has been terminated.
Sponsor:
Zeria Pharmaceutical
Information provided by:
Zeria Pharmaceutical
ClinicalTrials.gov Identifier:
NCT00016692
First received: May 24, 2001
Last updated: April 26, 2006
Last verified: April 2001
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Estimated Primary Completion Date: | No date given |